» Articles » PMID: 9524360

Procollagen N-proteinase and Procollagen C-proteinase. Two Unusual Metalloproteinases That Are Essential for Procollagen Processing Probably Have Important Roles in Development and Cell Signaling

Overview
Journal Matrix Biol
Publisher Elsevier
Date 1998 Apr 3
PMID 9524360
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

As soon as procollagen precursors of fibrillar collagens were discovered in the early 1970s, it became apparent that connective tissues must contain proteolytic activities that cleave the N-propeptides and the C-propeptides from procollagens. Isolation and characterization of the enzymic activities, however, proved to be unexpectedly difficult. Both proteinases are large and are synthesized in several different forms with polypeptide chains ranging in size from 70 kDa to about 130 kDa. The N-proteinase has the unusual property of cleaving the N-propeptides from type I and type II procollagens if the proteins are in a native conformation, but not if the proteins are partially unfolded so that the N-telopeptides are no longer in a hair-pin configuration. The C-proteinase specifically cleaves native and denatured types I, II and III procollagens. It also specifically cleaves a precursor of lysyl oxidase and laminin 5. Both enzymes and their variants have structures that place them in a large and expanding super-family of over 200 zinc-binding metalloproteinases. The larger of two forms of the N-proteinase contains an RGD sequence for binding through integrins and properdin repeats similar to those found in thrombospondin. The shorter 70 kDa form of the C-proteinase is identical to the protein that was previously identified as bone morphogenic protein-1. Both the 70 kDa C-proteinase and two larger forms are homologous to proteins that are expressed early in development in a variety of organisms, including Drosophila, sea urchin, and fish. Therefore, the data suggest that both the N- and C-proteinases have important biological functions in addition to the roles in the processing of procollagens.

Citing Articles

Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial.

Kolossvary M, Schnittman S, Zanni M, Fitch K, Fichtenbaum C, Aberg J JAMA Cardiol. 2024; 10(3):254-264.

PMID: 39661372 PMC: 11771813. DOI: 10.1001/jamacardio.2024.4115.


Systemic inhibition of bone morphogenetic protein 1.3 as a possible treatment for laminin-related congenital muscular dystrophy.

Matic Jelic I, Stokovic N, Ivanjko N, Pecina M, Kufner V, Bordukalo Niksic T Int Orthop. 2024; 49(1):45-52.

PMID: 39621123 DOI: 10.1007/s00264-024-06389-w.


Prognostic and therapeutic implications of tumor-restrictive type III collagen in the breast cancer microenvironment.

Stewart D, Brisson B, Dekky B, Berger A, Yen W, Mauldin E NPJ Breast Cancer. 2024; 10(1):86.

PMID: 39358397 PMC: 11447064. DOI: 10.1038/s41523-024-00690-y.


Development of a rapid, efficient, and reusable magnetic bead-based immunocapture system for recombinant human procollagen type II isolation from yeast fermentation broth.

Lioi M, Tengattini S, Bagatin F, Galliani S, Daly S, Massolini G Anal Bioanal Chem. 2023; 415(16):3155-3166.

PMID: 37246979 PMC: 10287800. DOI: 10.1007/s00216-023-04752-1.


A synthetic cell density signal can drive proliferation in chick embryonic tendon cells and tendon cells from a full size rooster can produce high levels of procollagen in cell culture.

Schwarz R PeerJ. 2022; 10:e14533.

PMID: 36530397 PMC: 9753744. DOI: 10.7717/peerj.14533.